vs

Side-by-side financial comparison of ENERPAC TOOL GROUP CORP (EPAC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

ENERPAC TOOL GROUP CORP is the larger business by last-quarter revenue ($144.2M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). ENERPAC TOOL GROUP CORP runs the higher net margin — 13.3% vs -38.1%, a 51.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 2.1%).

Enerpac Tool Group Corp., formerly Actuant Corporation, was founded in 1910 and is headquartered in Menomonee Falls, Wisconsin. Enerpac Tool Group common stock trades on the NYSE under the symbol EPAC.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

EPAC vs PRCT — Head-to-Head

Bigger by revenue
EPAC
EPAC
1.7× larger
EPAC
$144.2M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+20.9% gap
PRCT
20.2%
-0.7%
EPAC
Higher net margin
EPAC
EPAC
51.3% more per $
EPAC
13.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
2.1%
EPAC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EPAC
EPAC
PRCT
PRCT
Revenue
$144.2M
$83.1M
Net Profit
$19.1M
$-31.6M
Gross Margin
50.7%
64.9%
Operating Margin
19.8%
-4.1%
Net Margin
13.3%
-38.1%
Revenue YoY
-0.7%
20.2%
Net Profit YoY
-11.9%
-27.9%
EPS (diluted)
$0.36
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPAC
EPAC
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$144.2M
$76.4M
Q3 25
$167.5M
$83.3M
Q2 25
$158.7M
$79.2M
Q1 25
$145.5M
$69.2M
Q4 24
$145.2M
$68.2M
Q3 24
$158.7M
$58.4M
Q2 24
$150.4M
$53.4M
Net Profit
EPAC
EPAC
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$19.1M
$-29.8M
Q3 25
$28.1M
$-21.4M
Q2 25
$22.0M
$-19.6M
Q1 25
$20.9M
$-24.7M
Q4 24
$21.7M
$-18.9M
Q3 24
$24.4M
$-21.0M
Q2 24
$25.8M
$-25.6M
Gross Margin
EPAC
EPAC
PRCT
PRCT
Q1 26
64.9%
Q4 25
50.7%
60.6%
Q3 25
50.1%
64.8%
Q2 25
50.4%
65.4%
Q1 25
50.5%
63.9%
Q4 24
51.4%
64.0%
Q3 24
48.8%
63.2%
Q2 24
51.8%
59.0%
Operating Margin
EPAC
EPAC
PRCT
PRCT
Q1 26
-4.1%
Q4 25
19.8%
-40.6%
Q3 25
23.8%
-27.8%
Q2 25
20.0%
-28.0%
Q1 25
21.2%
-39.7%
Q4 24
21.4%
-28.9%
Q3 24
18.9%
-38.4%
Q2 24
22.2%
-50.3%
Net Margin
EPAC
EPAC
PRCT
PRCT
Q1 26
-38.1%
Q4 25
13.3%
-39.1%
Q3 25
16.8%
-25.7%
Q2 25
13.9%
-24.7%
Q1 25
14.4%
-35.8%
Q4 24
15.0%
-27.6%
Q3 24
15.4%
-35.9%
Q2 24
17.1%
-48.0%
EPS (diluted)
EPAC
EPAC
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.36
$-0.54
Q3 25
$0.51
$-0.38
Q2 25
$0.41
$-0.35
Q1 25
$0.38
$-0.45
Q4 24
$0.40
$-0.34
Q3 24
$0.44
$-0.40
Q2 24
$0.47
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPAC
EPAC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$139.0M
$245.6M
Total DebtLower is stronger
$188.8M
$51.7M
Stockholders' EquityBook value
$431.1M
$347.7M
Total Assets
$818.1M
$487.1M
Debt / EquityLower = less leverage
0.44×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPAC
EPAC
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$139.0M
$286.5M
Q3 25
$151.6M
$294.3M
Q2 25
$140.5M
$302.7M
Q1 25
$119.5M
$316.2M
Q4 24
$130.7M
$333.7M
Q3 24
$167.1M
$196.8M
Q2 24
$132.4M
$214.1M
Total Debt
EPAC
EPAC
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$188.8M
$51.6M
Q3 25
$190.0M
$51.6M
Q2 25
$191.3M
$51.5M
Q1 25
$192.5M
$51.5M
Q4 24
$193.8M
$51.5M
Q3 24
$195.0M
$51.4M
Q2 24
$196.3M
$51.4M
Stockholders' Equity
EPAC
EPAC
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$431.1M
$365.9M
Q3 25
$433.7M
$380.3M
Q2 25
$438.2M
$385.8M
Q1 25
$406.0M
$389.2M
Q4 24
$398.0M
$402.2M
Q3 24
$392.0M
$241.2M
Q2 24
$365.8M
$251.8M
Total Assets
EPAC
EPAC
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$818.1M
$508.1M
Q3 25
$827.9M
$511.5M
Q2 25
$828.1M
$513.1M
Q1 25
$776.6M
$519.4M
Q4 24
$775.4M
$534.0M
Q3 24
$777.3M
$374.1M
Q2 24
$749.5M
$374.4M
Debt / Equity
EPAC
EPAC
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.44×
0.14×
Q3 25
0.44×
0.14×
Q2 25
0.44×
0.13×
Q1 25
0.47×
0.13×
Q4 24
0.49×
0.13×
Q3 24
0.50×
0.21×
Q2 24
0.54×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPAC
EPAC
PRCT
PRCT
Operating Cash FlowLast quarter
$16.0M
Free Cash FlowOCF − Capex
$13.3M
FCF MarginFCF / Revenue
9.2%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
0.84×
TTM Free Cash FlowTrailing 4 quarters
$102.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPAC
EPAC
PRCT
PRCT
Q1 26
Q4 25
$16.0M
$-10.3M
Q3 25
$55.3M
$-6.6M
Q2 25
$39.9M
$-15.0M
Q1 25
$7.5M
$-17.0M
Q4 24
$8.6M
$-32.4M
Q3 24
$44.4M
$-18.8M
Q2 24
$30.3M
$-15.7M
Free Cash Flow
EPAC
EPAC
PRCT
PRCT
Q1 26
Q4 25
$13.3M
$-12.2M
Q3 25
$52.3M
$-9.5M
Q2 25
$35.1M
$-17.8M
Q1 25
$1.8M
$-18.8M
Q4 24
$2.8M
$-33.6M
Q3 24
$37.9M
$-19.0M
Q2 24
$28.5M
$-16.8M
FCF Margin
EPAC
EPAC
PRCT
PRCT
Q1 26
Q4 25
9.2%
-15.9%
Q3 25
31.2%
-11.4%
Q2 25
22.1%
-22.5%
Q1 25
1.2%
-27.2%
Q4 24
1.9%
-49.2%
Q3 24
23.9%
-32.6%
Q2 24
18.9%
-31.4%
Capex Intensity
EPAC
EPAC
PRCT
PRCT
Q1 26
Q4 25
1.9%
2.4%
Q3 25
1.8%
3.4%
Q2 25
3.1%
3.5%
Q1 25
3.9%
2.7%
Q4 24
4.0%
1.7%
Q3 24
4.1%
0.4%
Q2 24
1.2%
2.0%
Cash Conversion
EPAC
EPAC
PRCT
PRCT
Q1 26
Q4 25
0.84×
Q3 25
1.97×
Q2 25
1.81×
Q1 25
0.36×
Q4 24
0.40×
Q3 24
1.82×
Q2 24
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPAC
EPAC

Transferred At Point In Time$126.0M87%
Other$12.1M8%
Other Operating Segment$6.1M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons